Search Prime Grants

U01CA233078

Cooperative Agreement

Overview

Grant Description
N-glycosylation and immunotherapy for cancer.
Awardee
Irvine University Of California
Funding Goals
TO PROVIDE SUPPORT FOR INITIATIVES FUNDED UNDER THE 21ST CENTURY CURES ACT TO SUPPORT CANCER RESEARCH, SUCH AS THE DEVELOPMENT OF CANCER VACCINES, THE DEVELOPMENT OF MORE SENSITIVE DIAGNOSTIC TESTS FOR CANCER, IMMUNOTHERAPY AND THE DEVELOPMENT OF COMBINATION THERAPIES, AND RESEARCH THAT HAS THE POTENTIAL TO TRANSFORM THE SCIENTIFIC FIELD, THAT HAS INHERENTLY HIGHER RISK, AND THAT SEEKS TO ADDRESS MAJOR CHALLENGES RELATED TO CANCER.
Grant Program (CFDA)
93.353 - 21st Century Cures Act - Beau Biden Cancer Moonshot
Awarding / Funding Agency
National Cancer Institute (NCI) [HHS - NIH]
Place of Performance
Irvine, California 92697 United States
Geographic Scope
Single Zip Code
Related Opportunity
Immuno-Oncology Translational Network (IOTN): Cancer Immunotherapy Research Projects (U01) (RFA-CA-17-045)
Analysis Notes
Amendment Since initial award the End Date has been extended from 08/31/23 to 08/31/24 and the total obligations have increased 397% from $683,540 to $3,398,082.
Irvine University Of California was awarded N-glycosylation and Immunotherapy for cancer Cooperative Agreement U01CA233078 worth $3,398,082 from National Cancer Institute in September 2018 with work to be completed primarily in Irvine California United States. The grant has a duration of 6 years and was awarded through assistance program 93.353 21st Century Cures Act - Beau Biden Cancer Moonshot. The Cooperative Agreement was awarded through grant opportunity Immuno-Oncology Translational Network (IOTN): Cancer Immunotherapy Research Projects (U01).

Status
(Complete)

Last Modified 12/20/24

Period of Performance
9/21/18
Start Date
8/31/24
End Date
100% Complete

Funding Split
$3.4M
Federal Obligation
$0.0
Non-Federal Obligation
$3.4M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to U01CA233078

Transaction History

Modifications to U01CA233078

Additional Detail

Award ID FAIN
U01CA233078
SAI Number
U01CA233078-1078665529
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Funding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Awardee UEI
MJC5FCYQTPE6
Awardee CAGE
0VWL0
Performance District
CA-47
Senators
Dianne Feinstein
Alejandro Padilla

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) Health research and training Grants, subsidies, and contributions (41.0) $4,091,431 100%
Modified: 12/20/24